Your session is about to expire
← Back to Search
PT150 with alcohol consumption for Alcohol Treatment
Study Summary
This trial will study how alcohol interacts with the drug PT150 given to people who have experience with alcohol.
- Alcohol Interaction Treatment
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- To be considered for medical detoxification, a person must have a score of 10 or less on the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) and have a blood alcohol level of 0.00% or less.Are willing and able to comply with the study schedule and protocol;
Do not have a history of significant allergic reactions to insect bites;
Do not have a history of significant adverse reactions to medications;
Do not have a history of significant illness or significant ongoing health problems;
Do not have a history of significant mental health problemsThe participant must be willing to comply with all study procedures and be available for the duration of the study.Women must either not be able to conceive (i.e., surgically sterilized, sterile, or post-menopausal) or using a non-hormonal, medically accepted form of contraception during the study and for at least 2 weeks after study completion, with or without additional hormonal contraceptionCan prove they are over the age of 18 and can give their full name and date of birth.have health insurance
We are looking for people who are:
Male or female, aged 21-64, and have health insurance.
- Group 1: PT150 with alcohol consumption
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could the concurrent ingestion of PT150 and alcohol be potentially risky?
"PT150's safety when combined with alcohol is rated a 1; this reflects the fact that there is limited data available concerning its efficacy and how it interacts with other substances."
What core aims is this clinical trial hoping to achieve?
"This clinical trial aims to determine the difference in time of one-half the maximum concentration of PT150 (t1/2PT150) over a given period. Secondary objectives include assessing the differences in t1/2EtOH, ECG abnormalities and diastolic blood pressure from ethanol alone to concurrent steady state of PT150 with ethanol exposure."
Is the age restriction for this experiment higher than seventy-five years?
"Appropriate applicants for this trial should be between the ages of 21 and 64."
What is the participant count for this experiment?
"Affirmative. Clinicaltrials.gov corroborates the fact that this medical trial, which was initially published on November 1st 2021, is still actively seeking participants. The study needs to recruit 10 individuals from a single site."
How is PT150 commonly employed in conjunction with alcohol consumption?
"Obstructive hypertrophic cardiomyopathy is typically managed with PT150 and alcohol consumption. Furthermore, this protocol may be beneficial for treating communicable diseases, ethylene glycol intoxication, and skin disinfection therapy."
Are there still vacancies for volunteers in this medical research?
"According to clinicaltrials.gov, this trial is in the process of recruiting participants. The initial posting was on November 1st 2021 and it most recently updated on September 26th 2022."
What qualifications must be met in order to participate in this clinical experiment?
"This clinical trial seeks to recruit 10 individuals who are suffering from alcoholism and aged 21-64. Applicants must have a CIWA-Ar score of less than 10, consent to comply with all study proceedings, be able to provide proof of age and identity, not need medical detoxification as evidenced by a BAL ≤ 0.00%, not possess any clinically significant contraindications for study participation in the judgement of the admitting physician (as determined through self reported history and physical examination), women should either be sterile or use non-hormonal contraception during the course of the study plus two weeks after completion if they are capable of conceiving while"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- Michael E. DeBakey Veterans Affairs Medical Center: < 24 hours
Average response time
- < 1 Day
Typically responds via
Share this study with friends
Copy Link
Messenger